FUJIAN GLOBAL OCEAN BIOTECHNOLOGY CO.,LTD

Fujian Huanhai Biotechnology Co., Ltd. (stock name: Huanhai Biotech Stock Code: 838114) was established in 2010. It is a company jointly founded by three companies including Hong Kong Tongxin Investment Development Co., Ltd. and specializes in the research, development and production of seaweed hydrocolloids. It is a Sino-foreign joint venture technology enterprise that sells and sells products. Its subsidiaries include Jiangsu Global Marine Biotechnology Co., Ltd., Fujian Baoan Health Food Co., Ltd., and the holding company Fujian Haidebao Biotechnology Co., Ltd. It has a professional R&D institution and its team, and has extensive and in-depth cooperation and exchanges with large scientific research institutions and universities at home and abroad. The company uses high-quality seaweed from clean sea areas such as the Philippines and Indonesia, and extracts high-quality hydrocolloids through advanced processing techniques. The products have passed ISO9001, FSSC22000, ISO22000, KOSHER, HALAL and other standard system certifications. They are sold throughout the country and exported to Europe, the United States, and Japan. South Korea, Southeast Asia and many other countries and regions. The company's products include: agar, instant agar, red algae powder, agar oligosaccharide, agar oligosaccharide, organic red algae powder, culture medium agar, agarose, carrageenan, chitosan oligosaccharide, tremella oligosaccharide, compound products, Substitute tea, postbiotic algae oligosaccharide, postbiotic agar oligosaccharide solid drink, and nutritious algae drink. Products are widely used in food, daily chemicals, biology, medicine, aquaculture, agricultural protection and other fields. The company has always adhered to the business philosophy of "integrity management, customer first, people-oriented, harmony and win-win", providing ideal space for employees, creating high-quality products for customers, and creating a better life for the society.